Genome Editing Market – Global Industry Analysis and Forecast (2017-2026) _ by Technology (CRISPR, TALEN, ZFN, Antisense and Others Technologies), by Application, by End User and by Geography

Genome Editing Market – Global Industry Analysis and Forecast (2017-2026) _ by Technology (CRISPR, TALEN, ZFN, Antisense and Others Technologies), by Application, by End User and by Geography

Market Scenario

Genome Editing Market is expected to reach USD 12.92 Billion by 2026 from USD 3.25 Billion in 2016 at a CAGR of 14.8% (Detailed analysis of the market CAGR is provided in the report). Primarily genome editing is a type of genetic engineering in which DNA is inserted, modified, deleted or replaced in the genome of a living organism. This technology is also used for the disease extinction through direct correction of disturbances in genes, improving the immune response and alteration of pathogen targets. Global Genome Editing MarketThe genome editing market based on technology has been segmented into CRISPR, TALEN, ZFN, antisense and other technologies. The CRISPR segment is expected to be one of the major contributors for the market during the forecast period. The growth of this segment is attributed to the convenience of CRISPR technology. Based on application, the Genome Editing market is categorized into cell line engineering, genetic engineering, and other applications. The cell line engineering segment is estimated to have one of the largest shares of the market. This is due to the growing global awareness of stem cell therapies and increasing government and private funding. The genome editing market based on end user has been into pharmaceutical and biotechnology companies, academic & government research institutes and contract research organizations. The pharmaceutical and biotechnology companies segment is expected to hold one of the largest shares of the market during the forecast period. The growth of this segment is attributed to the rising incidence of infectious diseases, cancer, and other genetic disorders are tend to increase the research activities globally, thereby driving the growth of this segment. Geographically, the genome editing market has been segmented into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. North America is expected to be one of the largest markets for Genome Editing followed by Europe. The growth of this region is attributed to the improvement of gene therapy in the US, increasing incidence of infectious diseases and the rising use of genetically modified yields. The years that have been considered for the study are: • Base year – 2016 • Estimated year – 2017 • Forecast period – 2017 to 2026 Key Highlights: • Genome editing silicone market analysis and forecast, in terms of volume and value. • Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the genome editing market. • Genome editing market segmentation on the basis of technology, application, end user and geography (country-wise) has been provided. • Genome editing market strategic analysis with respect to individual growth trends, future prospects along with a contribution of various sub-market stakeholders have been considered under the scope of the study. • Genome editing market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation. • Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled. • Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the genome editing market are also profiled. Research Methodology: The market is estimated by triangulation of data points obtained from various sources and feeding them into a simulation model created individually for each market. The data points are obtained from paid and unpaid sources along with paid primary interviews with key opinion leaders (KOLs) in the market. KOLs from both, demand and supply side were considered while conducting interviews to get an unbiased idea of the market. This exercise was done at a country level to get a fair idea of the market in countries considered for this study. Later this country-specific data was accumulated to come up with regional numbers and then arrive at the global market value for Genome Editing Market. Some of them operating in the market are given underneath: • Thermo Fisher Scientific (US) • Horizon Discovery Group (UK) • Merck (Germany) • Genscript (US) • Integrated DNA Technologies (US) • Sangamo Biosciences (US) • Lonza (Switzerland) • Origene Technologies (US) • New England Biolabs (US) • Transposagen Biopharmaceuticals (US) Key Target Audience: • Suppliers and distributors of genome editing technologies • Research institutes • Vendors or service providers of genome editing Scope of the Report: The research report segments the genome editing market based on technology, application, end user and geography Genome Editing Market, by Technology: • CRISPR • TALEN • ZFN • Antisense • Other technologies Genome Editing Market, by Application: • Cell line Engineering • Genetic Engineering • Other Applications Genome Editing Market, by End User: • Biotechnology & Pharmaceutical Companies • Academic & Research Institutes • Contract Research Organizations Genome Editing Market, by Geography: • North America • Europe • Asia Pacific • Middle East & Africa • Latin America Geographic Analysis: • Breakdown of North America Genome Editing Market • Breakdown of Europe Genome Editing Market • Breakdown of Asia Pacific Genome Editing Market • Breakdown of Middle East & Africa Genome Editing Market • Breakdown of Latin America Genome Editing Market Available Customization: Maximize Market Research offers customization of reports according to the specific requirement of our clients Gene Editing Market: Global Industry Analysis and Forecast 2026

Table of Contents

1. EXECUTIVE SUMMARY 2. RESEARCH METHODOLOGY 2.1. Market Definition 2.2. Market Scope 2.3. Data Sources 3. MARKET DYNAMICS 3.1. Market Drivers 3.2. Market Restraints 3.3. Market Opportunities 4. END-USER OVERVIEW 4.1. Value Chain Analysis 4.2. Key Trends 5. GENOME EDITING MARKET, BY TECHNOLOGY (2016-2026) 5.1. Introduction 5.2. Genome Editing Market, by CRISPR 5.2.1. CRISPR Market Overview 5.2.2. CRISPR Market Size & Forecast 5.3. Genome Editing Market, by TALEN 5.3.1. TALEN Market Overview 5.3.2. TALEN Market Size & Forecast 5.4. Genome Editing Market, by ZFN 5.4.1. ZFN Market Overview 5.4.2. ZFN Market Size & Forecast 5.5. Genome Editing Market, by Antisense 5.5.1. Antisense Market Overview 5.5.2. Antisense Market Size & Forecast 5.6. Genome Editing Market, by Other Technologies 5.6.1. Other Technologies Market Overview 5.6.2. Other Technologies Market Size & Forecast 6. GENOME EDITING MARKET, BY APPLICATION (2016-2026) 6.1. Introduction 6.2. Genome Editing Market, by Cell Line Engineering 6.2.1. Cell Line Engineering Market Overview 6.2.2. Cell Line Engineering Market Size & Forecast 6.3. Genome Editing Market, by Genetic Engineering 6.3.1. Genetic Engineering Market Overview 6.3.2. Genetic Engineering Market Size & Forecast 6.3.2.1. Animal Genetic Engineering 6.3.2.2. Plant Genetic Engineering 6.4. Genome Editing Market, by Other Applications 6.4.1. Other Applications Market Overview 6.4.2. Other Applications Market Size & Forecast 7. GENOME EDITING MARKET, BY END USER (2016-2026) 7.1. Introduction 7.2. Genome Editing Market, by Biotechnology & Pharmaceutical Companies 7.2.1. Biotechnology & Pharmaceutical Companies Market Overview 7.2.2. Biotechnology & Pharmaceutical Companies Market Size & Forecast 7.3. Genome Editing Market, by Academic & Government Research Institutes 7.3.1. Academic & Government Research Institutes Market Overview 7.3.2. Academic & Government Research Institutes Market Size & Forecast 7.4. Genome Editing Market, by Contract Research Organizations 7.4.1. Contract Research Organizations Market Overview 7.4.2. Contract Research Organizations Market Size & Forecast 8. GENOME EDITING MARKET, BY GEOGRAPHY (2016-2026) 8.1. North America Genome Editing Market 8.1.1. North America Genome Editing Market, by Technology 8.1.2. North America Genome Editing Market, by Application 8.1.3. North America Genome Editing Market, by End-user 8.1.4. North America Genome Editing Market, by Region 8.1.4.1. U.S. Genome Editing Market 8.1.4.2. Canada Genome Editing Market 8.1.4.3. Rest of North America Genome Editing Market 8.2. Europe Genome Editing Market 8.2.1. Europe Genome Editing Market, by Technology 8.2.2. Europe Genome Editing Market, by Application 8.2.3. Europe Genome Editing Market, by End-user 8.2.4. Europe Genome Editing Market, by Region 8.2.4.1. France Genome Editing Market 8.2.4.2. Germany Genome Editing Market 8.2.4.3. U.K .Genome Editing Market 8.2.4.4. Rest of Europe Genome Editing Market 8.3. Asia Pacific Genome Editing Market 8.3.1. Asia-Pacific Genome Editing Market, by Technology 8.3.2. Asia-Pacific Genome Editing Market, by Application 8.3.3. Asia-Pacific Genome Editing Market, by End-user 8.3.4. Asia-Pacific Genome Editing Market, by Region 8.3.4.1. China Genome Editing Market 8.3.4.2. Japan Genome Editing Market 8.3.4.3. India Genome Editing Market 8.3.4.4. Australia Genome Editing Market 8.3.4.5. South Korea Genome Editing Market 8.3.4.6. Rest of Asia Pacific Genome Editing Market 8.4. Middle East & Africa Genome Editing Market 8.4.1. Middle East & Africa Genome Editing Market, by Technology 8.4.2. Middle East & Africa Genome Editing Market, by Application 8.4.3. Middle East & Africa Genome Editing Market, by End-user 8.4.4. Middle East & Africa Genome Editing Market, by Region 8.4.4.1. South Africa Genome Editing Market 8.4.4.2. Egypt Genome Editing Market 8.4.4.3. Nigeria Genome Editing Market 8.4.4.4. Rest of Middle East & Africa Genome Editing Market 8.5. Latin America Genome Editing Market 8.5.1. Latin America Genome Editing Market, by Technology 8.5.2. Latin America Genome Editing Market, by Application 8.5.3. Latin America Genome Editing Market, by End-user 8.5.4. Latin America Genome Editing Market, by Region 8.5.4.1. Brazil Genome Editing Market 8.5.4.2. Argentina Genome Editing Market 8.5.4.3. Columbia Genome Editing Market 8.5.4.4. Mexico Genome Editing Market 8.5.4.5. Rest of Latin America Genome Editing Market 9. MARKET COMPETITION ANALYSIS 9.1 Market Share/Positioning Analysis 9.2 Key Innovators 9.3 Company Profiles 9.3.1 Thermo Fisher Scientific 9.3.1.1 Overview 9.3.1.2 Products/ End-User 9.3.1.3 Strategy 9.3.1.4 Key Developments 9.3.2 Horizon Discovery Group 9.3.2.1 Overview 9.3.2.2 Products/ End-User 9.3.2.3 Strategy 9.3.2.4 Key Developments 9.3.3 Merck 9.3.3.1 Overview 9.3.3.2 Products/ End-User 9.3.3.3 Strategy 9.3.3.4 Key Developments 9.3.4 Genscript 9.3.4.1 Overview 9.3.4.2 Products/ End-User 9.3.4.3 Strategy 9.3.4.4 Key Developments 9.3.5 Integrated DNA Technologies 9.3.5.1 Overview 9.3.5.2 Products/ End-User 9.3.5.3 Strategy 9.3.5.4 Key Developments 9.3.6 Sangamo Biosciences 9.3.6.1 Overview 9.3.6.2 Products/ End-User 9.3.6.3 Strategy 9.3.6.4 Key Developments 9.3.7 Lonza 9.3.7.1 Overview 9.3.7.2 Products/ End-User 9.3.7.3 Strategy 9.3.7.4 Key Developments 9.3.8 Origene Technologies 9.3.8.1 Overview 9.3.8.2 Products/ End-User 9.3.8.3 Strategy 9.3.8.4 Key Developments 9.3.9 New England Biolabs 9.3.9.1 Overview 9.3.9.2 Products/ End-User 9.3.9.3 Strategy 9.3.9.4 Key Developments 9.3.10 Transposagen Biopharmaceuticals 9.3.10.1 Overview 9.3.10.2 Products/ End-User 9.3.10.3 Strategy 9.3.10.4 Key Developments

About This Report

Report ID2747
Published Date
Contact Us
Call Now